Response rates by disease status
| Disease status . | No. . | CR . | PR . | Response rate (%) . | 95% CI . |
|---|---|---|---|---|---|
| Rituximab naïve | 3 | 1 | 1 | 66.7 | 9.4-99.2 |
| Rituximab sensitive | 19 | 3 | 7 | 52.6 | 28.9-75.6 |
| Rituximab refractory | 18 | 1 | 2 | 16.7 | 3.6-41.4 |
| Chemotherapy sensitive* | 26 | 4 | 7 | 42.3 | 23.4-63.1 |
| Chemotherapy refractory* | 14 | 1 | 3 | 28.6 | 8.4-58.1 |
| Disease status . | No. . | CR . | PR . | Response rate (%) . | 95% CI . |
|---|---|---|---|---|---|
| Rituximab naïve | 3 | 1 | 1 | 66.7 | 9.4-99.2 |
| Rituximab sensitive | 19 | 3 | 7 | 52.6 | 28.9-75.6 |
| Rituximab refractory | 18 | 1 | 2 | 16.7 | 3.6-41.4 |
| Chemotherapy sensitive* | 26 | 4 | 7 | 42.3 | 23.4-63.1 |
| Chemotherapy refractory* | 14 | 1 | 3 | 28.6 | 8.4-58.1 |
On the basis of response to most recent prior chemotherapy.